High volume hemofiltration in critically ill patients: why, when and how?
Tetta
Ciro
C
Research Extracorporeal Therapies, Fresenius Medical Care Deutschland GmbH, Bad Homburg, Germany. ciro.tetta@fmc-ag.com
Bellomo
Rinaldo
R
Kellum
John
J
Ricci
Zaccaria
Z
Pohlmeiere
Robert
R
Passlick-Deetjen
Jutta
J
Ronco
Claudio
C
D016638:Critical Illness / Q000628:therapy*; D006440:Hemofiltration / Q000379:methods; D006801:Humans